$AVNS
AVANOS MEDICAL, INC. Stock $avns

$avns Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000160649823000069 Filed on August 09, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q2
Revenue	$171.3M	$169.4M	$203.0M
YoY Change	-15.24%	-16.55%	8.91%
Cost Of Revenue	$75.80M	$71.60M	$88.10M
YoY Change	-17.61%	-18.73%	-12.51%
Gross Profit	$95.50M	$97.80M	$114.9M
YoY Change	-13.26%	-14.88%	34.07%
Gross Profit Margin	55.75%	57.73%	56.6%
Selling, General & Admin	$78.70M	$93.00M	$87.10M
YoY Change	-4.14%	6.77%	13.56%
% of Gross Profit	82.41%	95.09%	75.81%
Research & Development	$6.100M	$6.800M	$8.000M
YoY Change	-16.44%	-15.0%	0.0%
% of Gross Profit	6.39%	6.95%	6.96%
Depreciation & Amortization	$4.800M	$4.500M	$11.60M
YoY Change	-12.73%	-61.21%	114.81%
% of Gross Profit	5.03%	4.6%	10.1%
Operating Expenses	$84.80M	$99.80M	$95.90M
YoY Change	-5.15%	4.07%	13.22%
Operating Profit	$1.200M	-$2.100M	$19.00M
YoY Change	-93.58%	-111.05%	-360.27%
Interest Expense	$4.700M	$3.500M	-$2.500M
YoY Change	56.67%	-240.0%	-377.78%
% of Operating Profit	391.67%		-13.16%
Other Income/Expense, Net
YoY Change
Pretax Income	-$2.600M	-$5.100M	$16.50M
YoY Change	-116.25%	-130.91%	-301.22%
Income Tax	$6.200M	-$800.0K	$5.100M
% Of Pretax Income			30.91%
Net Earnings	-$3.700M	-$68.10M	$11.40M
YoY Change	-123.57%	-697.37%	-69.92%
Net Earnings / Revenue	-2.16%	-40.2%	5.62%
Basic Earnings Per Share	-$0.08	-$1.46	$0.27
Diluted Earnings Per Share	-$0.08	-$1.46	$239.5K
COMMON SHARES
Basic Shares Outstanding	46.87M shares	46.67M shares	47.32M shares
Diluted Shares Outstanding	46.80M shares	46.80M shares	47.60M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$107.1M	$81.80M	$106.5M
YoY Change	-8.46%	-23.19%	6.61%
Cash & Equivalents	$107.1M	$81.80M	$106.5M
Short-Term Investments
Other Short-Term Assets	$115.7M	$124.5M	$16.20M
YoY Change	776.52%	668.52%	-13.83%
Inventory	$156.6M	$148.3M	$169.0M
Prepaid Expenses
Receivables	$132.2M	$139.4M	$137.5M
Other Receivables	$13.00M	$12.90M	$7.900M
Total Short-Term Assets	$524.6M	$506.9M	$437.1M
YoY Change	11.62%	15.97%	-1.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$116.8M	$122.6M	$198.2M
YoY Change	-28.52%	-38.14%	15.3%
Goodwill	$791.5M	$762.6M
YoY Change	-3.9%
Intangibles	$242.2M	$222.6M
YoY Change	-6.38%
Long-Term Investments
YoY Change
Other Assets	$18.40M	$18.50M	$27.60M
YoY Change	14.29%	-32.97%	150.91%
Total Long-Term Assets	$1.200B	$1.160B	$1.316B
YoY Change	-8.04%	-11.85%	6.12%
TOTAL ASSETS
Total Short-Term Assets	$524.6M	$506.9M	$437.1M
Total Long-Term Assets	$1.200B	$1.160B	$1.316B
Total Assets	$1.725B	$1.667B	$1.753B
YoY Change	-2.83%	-4.91%	4.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$52.10M	$65.40M	$64.20M
YoY Change	-16.91%	1.87%	-1.98%
Accrued Expenses	$97.20M	$72.70M	$82.20M
YoY Change	21.5%	-11.56%	5.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$6.200M	$6.200M	$4.700M
YoY Change	0.0%	31.91%
Total Short-Term Liabilities	$170.7M	$160.5M	$151.1M
YoY Change	5.18%	6.22%	-4.55%
LONG-TERM LIABILITIES
Long-Term Debt	$258.3M	$203.3M	$249.3M
YoY Change	4.24%	-18.45%	51.09%
Other Long-Term Liabilities	$15.60M	$15.40M	$66.10M
YoY Change	-43.88%	-76.7%	523.58%
Total Long-Term Liabilities	$15.60M	$15.40M	$315.4M
YoY Change	-43.88%	-95.12%	2875.47%
TOTAL LIABILITIES
Total Short-Term Liabilities	$170.7M	$160.5M	$151.1M
Total Long-Term Liabilities	$15.60M	$15.40M	$315.4M
Total Liabilities	$502.8M	$431.9M	$501.2M
YoY Change	-1.74%	-13.83%	29.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$325.4M	-$321.7M
YoY Change	20.52%
Common Stock	$500.0K	$500.0K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.222B	$1.235B	$1.252B
YoY Change
Total Liabilities & Shareholders Equity	$1.725B	$1.667B	$1.753B
YoY Change	-2.83%	-4.91%	4.13%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$3.700M	-$68.10M	$11.40M
YoY Change	-123.57%	-697.37%	-69.92%
Depreciation, Depletion And Amortization	$4.800M	$4.500M	$11.60M
YoY Change	-12.73%	-61.21%	114.81%
Cash From Operating Activities	$29.10M	-$2.600M	$27.00M
YoY Change	2.46%	-109.63%	76.47%
INVESTING ACTIVITIES
Capital Expenditures	$3.900M	$4.000M	-$4.100M
YoY Change	-173.58%	-197.56%	-29.31%
Acquisitions
YoY Change
Other Investing Activities	-$45.00M	-$2.500M	$0.00
YoY Change	-7600.0%
Cash From Investing Activities	-$48.90M	-$6.500M	-$4.100M
YoY Change	940.43%	58.54%	-29.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	46.70M	-4.100M	-16.90M
YoY Change	-557.84%	-75.74%	67.33%
NET CHANGE
Cash From Operating Activities	29.10M	-2.600M	27.00M
Cash From Investing Activities	-48.90M	-6.500M	-4.100M
Cash From Financing Activities	46.70M	-4.100M	-16.90M
Net Change In Cash	26.90M	-13.20M	6.000M
YoY Change	99.26%	-320.0%	-1100.0%
FREE CASH FLOW
Cash From Operating Activities	$29.10M	-$2.600M	$27.00M
Capital Expenditures	$3.900M	$4.000M	-$4.100M
Free Cash Flow	$25.20M	-$6.600M	$31.10M
YoY Change	-25.22%	-121.22%	47.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Net Income Loss NetIncomeLoss	-68600000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	59100000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-18900000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6900000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	13100000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18000000.0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-400000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-600000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1800000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	33500000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-37100000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-28500000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1300000	usd
	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	28800000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	8000000.0	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	9100000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2500000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	116700000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-125800000	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	usd
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	250000000.0	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	3100000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	125000000.0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	150000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	20000000.0	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	150000000.0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3700000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34100000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2900000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	600000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	800000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26200000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	88800000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	200000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-3800000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-45900000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-12000000.0	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	127700000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	118500000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	81800000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of our condensed consolidated financial statements in accordance with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of net sales and expenses during the reporting periods. Estimates are used in accounting for, among other things, certain amounts included in discontinued operations, certain amounts included in assets and liabilities held for sale, distributor rebate accruals, future cash flows associated with impairment testing for goodwill and long-lived assets, loss contingencies, and deferred tax assets and potential income tax assessments. Actual results could differ from these estimates, and the effect of any change could be material to our financial statements. Changes in these estimates are recorded when known.</span></div>
CY2023Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	43500000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	36700000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	23700000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	23800000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	77800000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	69800000	usd
CY2023Q1	avns	Restructuring Plan Term RestructuringPlanTerm	P3Y
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	146100000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	162100000	usd
CY2023Q2	us-gaap	Income Tax Receivable IncomeTaxReceivable	12900000	usd
CY2022Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	12200000	usd
CY2023Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	152300000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	167900000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	400000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	600000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	300000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	600000	usd
CY2023Q2	us-gaap	Other Inventory Supplies OtherInventorySupplies	3300000	usd
CY2022Q4	us-gaap	Other Inventory Supplies OtherInventorySupplies	2000000.0	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	148300000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	132300000	usd
CY2023Q2	us-gaap	Inventory Write Down InventoryWriteDown	2400000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	4300000	usd
CY2022Q2	us-gaap	Inventory Write Down InventoryWriteDown	1700000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	6200000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	238200000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	223400000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	115600000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	104800000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	122600000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	118600000	usd
CY2023Q2	us-gaap	Depreciation Depreciation	4500000	usd
	us-gaap	Depreciation Depreciation	9400000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	4400000	usd
	us-gaap	Depreciation Depreciation	8800000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	760300000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	1800000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-500000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	762600000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	468900000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	246300000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	222600000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	468900000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	234700000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	234200000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5800000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	11600000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5700000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10900000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	11800000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	23200000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	22700000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	22200000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	22000000.0	usd
CY2023Q2	avns	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	120700000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	222600000	usd
CY2023Q2	avns	Accrued Rebates And Customer Incentives AccruedRebatesAndCustomerIncentives	20700000	usd
CY2022Q4	avns	Accrued Rebates And Customer Incentives AccruedRebatesAndCustomerIncentives	26900000	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	28200000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	34600000	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	5800000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	21200000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18000000.0	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16200000	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	72700000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	98900000	usd
CY2023Q2	avns	Accrued Compensation Benefits AccruedCompensationBenefits	5800000	usd
CY2022Q4	avns	Accrued Compensation Benefits AccruedCompensationBenefits	4800000	usd
CY2023Q2	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	9600000	usd
CY2022Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	18700000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15400000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23500000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	210300000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	233400000	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	800000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	900000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	6200000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	6200000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	203300000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	226300000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3100000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7000000.0	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	9400000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	10200000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	180600000	usd
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	210300000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7400000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2900000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-5700000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	7400000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-4000000.0	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2900000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-5700000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7400000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-4000000.0	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3900000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4000000.0	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7900000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7800000	usd
CY2021Q3	us-gaap	Loss Contingency Accrual Payments LossContingencyAccrualPayments	22200000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-4300000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4800000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12100000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	800000	usd
CY2023Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-63800000	usd
CY2022Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	7700000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-56500000	usd
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	17100000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-68100000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	12500000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-68600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	17900000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46800000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47200000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46700000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47300000	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	400000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46800000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47600000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47700000	shares
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.09
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.10
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.26
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.02
CY2023Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.37
CY2022Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.17
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	-1.21
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.36
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.46
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.47
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.09
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.10
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.26
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.01
CY2023Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-1.37
CY2022Q2	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.16
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	-1.21
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.36
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.46
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.47
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.37
CY2023Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1900000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1300000	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169400000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	170900000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	328700000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	330200000	usd
CY2023Q2	avns	Accrued Rebates AccruedRebates	10600000	usd
CY2022Q4	avns	Accrued Rebates AccruedRebates	14500000	usd
CY2023Q2	avns	Accrued Incentives AccruedIncentives	10100000	usd
CY2022Q4	avns	Accrued Incentives AccruedIncentives	12400000	usd
CY2023Q2	avns	Accrued Rebates And Incentives AccruedRebatesAndIncentives	20700000	usd
CY2022Q4	avns	Accrued Rebates And Incentives AccruedRebatesAndIncentives	26900000	usd
CY2023Q2	avns	Accrued Sales Returns AccruedSalesReturns	100000	usd
CY2022Q4	avns	Accrued Sales Returns AccruedSalesReturns	100000	usd
CY2023Q2	avns	Liabilities For Estimated Rebates And Incentives Net LiabilitiesForEstimatedRebatesAndIncentivesNet	20800000	usd
CY2022Q4	avns	Liabilities For Estimated Rebates And Incentives Net LiabilitiesForEstimatedRebatesAndIncentivesNet	27000000.0	usd

Files In Submission

Name	View Source	Status
0001606498-23-000069-index-headers.html	Edgar Link	pending
0001606498-23-000069-index.html	Edgar Link	pending
0001606498-23-000069.txt	Edgar Link	pending
0001606498-23-000069-xbrl.zip	Edgar Link	pending
avns-20230630.htm	Edgar Link	pending
avns-20230630.xsd	Edgar Link	pending
avns-20230630_g1.jpg	Edgar Link	pending
avns2q2023form10qex31a.htm	Edgar Link	pending
avns2q2023form10qex31b.htm	Edgar Link	pending
avns2q2023form10qex32a.htm	Edgar Link	pending
avns2q2023form10qex32b.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
purchaseagreementdatedjune.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
avns-20230630_cal.xml	Edgar Link	unprocessable
avns-20230630_def.xml	Edgar Link	unprocessable
avns-20230630_lab.xml	Edgar Link	unprocessable
avns-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
avns-20230630_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVNS
AVANOS MEDICAL, INC. Stock $avns

2023 Q3 Form 10-Q Financial Statement

#000160649823000069 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNS AVANOS MEDICAL, INC. Stock $avns

2023 Q3 Form 10-Q Financial Statement

#000160649823000069 Filed on August 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNS
AVANOS MEDICAL, INC. Stock $avns